Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Biokinetics Study for Tc-99m MAG3 Dose Reduction in Pediatric Molecular Imaging

NCT03107286 is registered in ClinicalTrials.gov with Boston Children's Hospital as lead sponsor.

NCT NCT03107286
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03107286 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Biokinetics Study for Tc-99m MAG3 Dose Reduction in Pediatric Molecular Imaging
Lead sponsor
Boston Children's Hospital
Phase
Observational
Overall status
Completed
Start date
January 2, 2018
Completion date
October 6, 2021
Enrollment
18 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

renal disease